{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 3491, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de075-3c48-75dd-a16f-ddcce5fecf48", "docSlug": "20dccf7a034b09514201ed73755b4bbb", "documentTitle": "Absci | Investor Presentation Deck | 48 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 32, "slideType": "traction", "function": "show_traction", "notes": "The slide highlights the scale of the antibody discovery pipeline and the distribution of therapeutic focus areas.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3c48-75dd-a16f-ddcce5fecf48/32", "deckHref": "/decks/019de075-3c48-75dd-a16f-ddcce5fecf48", "deckAnchorHref": "/decks/019de075-3c48-75dd-a16f-ddcce5fecf48#slide-32", "loopMatches": [], "arcBeatMatches": [ { "to": 48, "from": 6, "beatId": "7c165ad6-f743-4405-9aff-e111239d7bcd", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 6-48 present Absci's AI-powered solution for biologic drug creation", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3c48-75dd-a16f-ddcce5fecf48", "docSlug": "20dccf7a034b09514201ed73755b4bbb", "documentTitle": "Absci | Investor Presentation Deck | 48 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 33, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a two-column layout to contrast the partners (left) with the value derived from those partnerships (right).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3c48-75dd-a16f-ddcce5fecf48/33", "deckHref": "/decks/019de075-3c48-75dd-a16f-ddcce5fecf48", "deckAnchorHref": "/decks/019de075-3c48-75dd-a16f-ddcce5fecf48#slide-33", "loopMatches": [], "arcBeatMatches": [ { "to": 48, "from": 6, "beatId": "7c165ad6-f743-4405-9aff-e111239d7bcd", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 6-48 present Absci's AI-powered solution for biologic drug creation", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3c48-75dd-a16f-ddcce5fecf48", "docSlug": "20dccf7a034b09514201ed73755b4bbb", "documentTitle": "Absci | Investor Presentation Deck | 48 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 34, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a linear process flow to demonstrate the platform's capabilities.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3c48-75dd-a16f-ddcce5fecf48/34", "deckHref": "/decks/019de075-3c48-75dd-a16f-ddcce5fecf48", "deckAnchorHref": "/decks/019de075-3c48-75dd-a16f-ddcce5fecf48#slide-34", "loopMatches": [], "arcBeatMatches": [ { "to": 48, "from": 6, "beatId": "7c165ad6-f743-4405-9aff-e111239d7bcd", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 6-48 present Absci's AI-powered solution for biologic drug creation", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3c48-75dd-a16f-ddcce5fecf48", "docSlug": "20dccf7a034b09514201ed73755b4bbb", "documentTitle": "Absci | Investor Presentation Deck | 48 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 35, "slideType": "solution", "function": "present_solution", "notes": "The slide explains the mechanism of incorporating nsAA into mAbs to create ADC precursors.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3c48-75dd-a16f-ddcce5fecf48/35", "deckHref": "/decks/019de075-3c48-75dd-a16f-ddcce5fecf48", "deckAnchorHref": "/decks/019de075-3c48-75dd-a16f-ddcce5fecf48#slide-35", "loopMatches": [], "arcBeatMatches": [ { "to": 48, "from": 6, "beatId": "7c165ad6-f743-4405-9aff-e111239d7bcd", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 6-48 present Absci's AI-powered solution for biologic drug creation", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3c48-75dd-a16f-ddcce5fecf48", "docSlug": "20dccf7a034b09514201ed73755b4bbb", "documentTitle": "Absci | Investor Presentation Deck | 48 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 36, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a split-column layout to contrast the platform's technical capability with its practical application.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3c48-75dd-a16f-ddcce5fecf48/36", "deckHref": "/decks/019de075-3c48-75dd-a16f-ddcce5fecf48", "deckAnchorHref": "/decks/019de075-3c48-75dd-a16f-ddcce5fecf48#slide-36", "loopMatches": [], "arcBeatMatches": [ { "to": 48, "from": 6, "beatId": "7c165ad6-f743-4405-9aff-e111239d7bcd", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 6-48 present Absci's AI-powered solution for biologic drug creation", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3c48-75dd-a16f-ddcce5fecf48", "docSlug": "20dccf7a034b09514201ed73755b4bbb", "documentTitle": "Absci | Investor Presentation Deck | 48 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 37, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a series of diagrams to illustrate the biological engineering features of the cell line.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3c48-75dd-a16f-ddcce5fecf48/37", "deckHref": "/decks/019de075-3c48-75dd-a16f-ddcce5fecf48", "deckAnchorHref": "/decks/019de075-3c48-75dd-a16f-ddcce5fecf48#slide-37", "loopMatches": [], "arcBeatMatches": [ { "to": 48, "from": 6, "beatId": "7c165ad6-f743-4405-9aff-e111239d7bcd", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 6-48 present Absci's AI-powered solution for biologic drug creation", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3c48-75dd-a16f-ddcce5fecf48", "docSlug": "20dccf7a034b09514201ed73755b4bbb", "documentTitle": "Absci | Investor Presentation Deck | 48 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 38, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a bar chart to show that even with 3 nsAA sites, the relative expression remains comparable to wild-type, validating the platform's efficiency.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3c48-75dd-a16f-ddcce5fecf48/38", "deckHref": "/decks/019de075-3c48-75dd-a16f-ddcce5fecf48", "deckAnchorHref": "/decks/019de075-3c48-75dd-a16f-ddcce5fecf48#slide-38", "loopMatches": [], "arcBeatMatches": [ { "to": 48, "from": 6, "beatId": "7c165ad6-f743-4405-9aff-e111239d7bcd", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 6-48 present Absci's AI-powered solution for biologic drug creation", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3c48-75dd-a16f-ddcce5fecf48", "docSlug": "20dccf7a034b09514201ed73755b4bbb", "documentTitle": "Absci | Investor Presentation Deck | 48 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 39, "slideType": "product_demo", "function": "illustrate_case", "notes": "The slide uses a mass spectrometry plot to show the shift in molecular mass after conjugation, highlighting the precision of the Absci platform.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3c48-75dd-a16f-ddcce5fecf48/39", "deckHref": "/decks/019de075-3c48-75dd-a16f-ddcce5fecf48", "deckAnchorHref": "/decks/019de075-3c48-75dd-a16f-ddcce5fecf48#slide-39", "loopMatches": [], "arcBeatMatches": [ { "to": 48, "from": 6, "beatId": "7c165ad6-f743-4405-9aff-e111239d7bcd", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 6-48 present Absci's AI-powered solution for biologic drug creation", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3c48-75dd-a16f-ddcce5fecf48", "docSlug": "20dccf7a034b09514201ed73755b4bbb", "documentTitle": "Absci | Investor Presentation Deck | 48 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 40, "slideType": "solution", "function": "present_solution", "notes": "Uses a four-column layout to categorize value propositions.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3c48-75dd-a16f-ddcce5fecf48/40", "deckHref": "/decks/019de075-3c48-75dd-a16f-ddcce5fecf48", "deckAnchorHref": "/decks/019de075-3c48-75dd-a16f-ddcce5fecf48#slide-40", "loopMatches": [ { "to": 43, "from": 40, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "532b5140-e345-4472-8b69-11d6e258b0de", "evidence": "Slides 40-43 present Absci's value creation strategy for patients and partners", "position": 1, "objective": "How can Absci create value for patients and partners?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 48, "from": 6, "beatId": "7c165ad6-f743-4405-9aff-e111239d7bcd", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 6-48 present Absci's AI-powered solution for biologic drug creation", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3c48-75dd-a16f-ddcce5fecf48", "docSlug": "20dccf7a034b09514201ed73755b4bbb", "documentTitle": "Absci | Investor Presentation Deck | 48 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 41, "slideType": "solution", "function": "present_solution", "notes": "PoS stands for Probability of Success. The slide uses a timeline framework to contrast traditional drug development with Absci's approach.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3c48-75dd-a16f-ddcce5fecf48/41", "deckHref": "/decks/019de075-3c48-75dd-a16f-ddcce5fecf48", "deckAnchorHref": "/decks/019de075-3c48-75dd-a16f-ddcce5fecf48#slide-41", "loopMatches": [ { "to": 43, "from": 40, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "532b5140-e345-4472-8b69-11d6e258b0de", "evidence": "Slides 40-43 present Absci's value creation strategy for patients and partners", "position": 1, "objective": "How can Absci create value for patients and partners?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 48, "from": 6, "beatId": "7c165ad6-f743-4405-9aff-e111239d7bcd", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 6-48 present Absci's AI-powered solution for biologic drug creation", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3c48-75dd-a16f-ddcce5fecf48", "docSlug": "20dccf7a034b09514201ed73755b4bbb", "documentTitle": "Absci | Investor Presentation Deck | 48 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 42, "slideType": "business_model", "function": "present_solution", "notes": "Uses a dot-plot style bar chart to represent revenue over a 25-year period.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3c48-75dd-a16f-ddcce5fecf48/42", "deckHref": "/decks/019de075-3c48-75dd-a16f-ddcce5fecf48", "deckAnchorHref": "/decks/019de075-3c48-75dd-a16f-ddcce5fecf48#slide-42", "loopMatches": [ { "to": 43, "from": 40, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "532b5140-e345-4472-8b69-11d6e258b0de", "evidence": "Slides 40-43 present Absci's value creation strategy for patients and partners", "position": 1, "objective": "How can Absci create value for patients and partners?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 48, "from": 6, "beatId": "7c165ad6-f743-4405-9aff-e111239d7bcd", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 6-48 present Absci's AI-powered solution for biologic drug creation", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3c48-75dd-a16f-ddcce5fecf48", "docSlug": "20dccf7a034b09514201ed73755b4bbb", "documentTitle": "Absci | Investor Presentation Deck | 48 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 43, "slideType": "traction", "function": "show_traction", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3c48-75dd-a16f-ddcce5fecf48/43", "deckHref": "/decks/019de075-3c48-75dd-a16f-ddcce5fecf48", "deckAnchorHref": "/decks/019de075-3c48-75dd-a16f-ddcce5fecf48#slide-43", "loopMatches": [ { "to": 43, "from": 40, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "532b5140-e345-4472-8b69-11d6e258b0de", "evidence": "Slides 40-43 present Absci's value creation strategy for patients and partners", "position": 1, "objective": "How can Absci create value for patients and partners?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 48, "from": 6, "beatId": "7c165ad6-f743-4405-9aff-e111239d7bcd", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 6-48 present Absci's AI-powered solution for biologic drug creation", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3c48-75dd-a16f-ddcce5fecf48", "docSlug": "20dccf7a034b09514201ed73755b4bbb", "documentTitle": "Absci | Investor Presentation Deck | 48 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 44, "slideType": "testimonial", "function": "show_traction", "notes": "Uses authority-citation to build credibility.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3c48-75dd-a16f-ddcce5fecf48/44", "deckHref": "/decks/019de075-3c48-75dd-a16f-ddcce5fecf48", "deckAnchorHref": "/decks/019de075-3c48-75dd-a16f-ddcce5fecf48#slide-44", "loopMatches": [], "arcBeatMatches": [ { "to": 48, "from": 6, "beatId": "7c165ad6-f743-4405-9aff-e111239d7bcd", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 6-48 present Absci's AI-powered solution for biologic drug creation", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3c48-75dd-a16f-ddcce5fecf48", "docSlug": "20dccf7a034b09514201ed73755b4bbb", "documentTitle": "Absci | Investor Presentation Deck | 48 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 45, "slideType": "team_bio", "function": "other", "notes": "Includes a dog (Penelope) as 'Chief Morale Officer', a common startup culture trope.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3c48-75dd-a16f-ddcce5fecf48/45", "deckHref": "/decks/019de075-3c48-75dd-a16f-ddcce5fecf48", "deckAnchorHref": "/decks/019de075-3c48-75dd-a16f-ddcce5fecf48#slide-45", "loopMatches": [], "arcBeatMatches": [ { "to": 48, "from": 6, "beatId": "7c165ad6-f743-4405-9aff-e111239d7bcd", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 6-48 present Absci's AI-powered solution for biologic drug creation", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3c48-75dd-a16f-ddcce5fecf48", "docSlug": "20dccf7a034b09514201ed73755b4bbb", "documentTitle": "Absci | Investor Presentation Deck | 48 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 46, "slideType": "team_bio", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3c48-75dd-a16f-ddcce5fecf48/46", "deckHref": "/decks/019de075-3c48-75dd-a16f-ddcce5fecf48", "deckAnchorHref": "/decks/019de075-3c48-75dd-a16f-ddcce5fecf48#slide-46", "loopMatches": [], "arcBeatMatches": [ { "to": 48, "from": 6, "beatId": "7c165ad6-f743-4405-9aff-e111239d7bcd", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 6-48 present Absci's AI-powered solution for biologic drug creation", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3c48-75dd-a16f-ddcce5fecf48", "docSlug": "20dccf7a034b09514201ed73755b4bbb", "documentTitle": "Absci | Investor Presentation Deck | 48 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 47, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a growth curve to illustrate technological progression over time.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3c48-75dd-a16f-ddcce5fecf48/47", "deckHref": "/decks/019de075-3c48-75dd-a16f-ddcce5fecf48", "deckAnchorHref": "/decks/019de075-3c48-75dd-a16f-ddcce5fecf48#slide-47", "loopMatches": [], "arcBeatMatches": [ { "to": 48, "from": 6, "beatId": "7c165ad6-f743-4405-9aff-e111239d7bcd", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 6-48 present Absci's AI-powered solution for biologic drug creation", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3c48-75dd-a16f-ddcce5fecf48", "docSlug": "20dccf7a034b09514201ed73755b4bbb", "documentTitle": "Absci | Investor Presentation Deck | 48 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 48, "slideType": "closing_ask", "function": "state_next_steps", "notes": "The slide uses a high-contrast visual style with a black-and-white lab photo and a stylized red-and-black graphic element.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3c48-75dd-a16f-ddcce5fecf48/48", "deckHref": "/decks/019de075-3c48-75dd-a16f-ddcce5fecf48", "deckAnchorHref": "/decks/019de075-3c48-75dd-a16f-ddcce5fecf48#slide-48", "loopMatches": [], "arcBeatMatches": [ { "to": 48, "from": 6, "beatId": "7c165ad6-f743-4405-9aff-e111239d7bcd", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 6-48 present Absci's AI-powered solution for biologic drug creation", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/DW4xSllPctnzlqJ3bXDRgoZZDraFANLKCpS9ZLarT9A/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy84YzJkNjI5YTkwOTc0NzQzYmU3ZDE1ZjE2YTIzZTUwZi9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/1", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-1", "loopMatches": [], "arcBeatMatches": [ { "to": 4, "from": 1, "beatId": "e1ceccc7-d9f1-43f8-940e-04c5912c3a13", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Setup", "beatSlug": "setup", "evidence": "The document sets up the company and its mission", "position": 0, "confidence": 0.9, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": "https://imgproxy.kitesheet.com/alZYiUoE28WUarGjF85y2afTqU2-o5QEmFzDHm3p3gE/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy84YzJkNjI5YTkwOTc0NzQzYmU3ZDE1ZjE2YTIzZTUwZi9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/Ifin-1l1PPTIOZ4l_WUmp_0pjcQqQbtqDAQ3oWnMEco/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy84YzJkNjI5YTkwOTc0NzQzYmU3ZDE1ZjE2YTIzZTUwZi9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/_ObmrCmtOWbpDEXBzluZ2mLnMnK7nP8D4QQGQ7kuhZU/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy84YzJkNjI5YTkwOTc0NzQzYmU3ZDE1ZjE2YTIzZTUwZi9wMDAxLnBuZw" }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "appendix_disclosure", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/2", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-2", "loopMatches": [], "arcBeatMatches": [ { "to": 4, "from": 1, "beatId": "e1ceccc7-d9f1-43f8-940e-04c5912c3a13", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Setup", "beatSlug": "setup", "evidence": "The document sets up the company and its mission", "position": 0, "confidence": 0.9, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "other", "function": "summarize", "notes": "The slide details a corporate M&A event and associated private placement financing.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/3", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-3", "loopMatches": [], "arcBeatMatches": [ { "to": 4, "from": 1, "beatId": "e1ceccc7-d9f1-43f8-940e-04c5912c3a13", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Setup", "beatSlug": "setup", "evidence": "The document sets up the company and its mission", "position": 0, "confidence": 0.9, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide provides a breakdown of shares and conversion ratios related to a merger and concurrent financing.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/4", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-4", "loopMatches": [], "arcBeatMatches": [ { "to": 4, "from": 1, "beatId": "e1ceccc7-d9f1-43f8-940e-04c5912c3a13", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Setup", "beatSlug": "setup", "evidence": "The document sets up the company and its mission", "position": 0, "confidence": 0.9, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a pipeline table format to show the progression of various drug candidates (SPY001-SPY230) across discovery, IND-enabling, and clinical stages.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/5", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-5", "loopMatches": [ { "to": 12, "from": 5, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "2c2ea794-d311-4166-8444-be0ff8d81ce6", "evidence": "The document uses the golden circle to explain the company's mission and vision", "position": 0, "objective": "Why is this important?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.8, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 8, "from": 5, "beatId": "50cfb41c-c55f-4d71-bad7-662cc5ddaf6c", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem (Identify pain)", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "The document identifies the problem and the need for new approaches", "position": 1, "confidence": 0.9, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The slide uses a donut chart to compare 2021 and 2028 market sizes, highlighting growth.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/6", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-6", "loopMatches": [ { "to": 12, "from": 5, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "2c2ea794-d311-4166-8444-be0ff8d81ce6", "evidence": "The document uses the golden circle to explain the company's mission and vision", "position": 0, "objective": "Why is this important?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.8, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 8, "from": 5, "beatId": "50cfb41c-c55f-4d71-bad7-662cc5ddaf6c", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem (Identify pain)", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "The document identifies the problem and the need for new approaches", "position": 1, "confidence": 0.9, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "market_sizing", "function": "size_opportunity", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/7", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-7", "loopMatches": [ { "to": 12, "from": 5, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "2c2ea794-d311-4166-8444-be0ff8d81ce6", "evidence": "The document uses the golden circle to explain the company's mission and vision", "position": 0, "objective": "Why is this important?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.8, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 8, "from": 5, "beatId": "50cfb41c-c55f-4d71-bad7-662cc5ddaf6c", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem (Identify pain)", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "The document identifies the problem and the need for new approaches", "position": 1, "confidence": 0.9, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "problem_statement", "function": "frame_problem", "notes": "The chart uses a visual metaphor of a 'ceiling' (the 40% remission line) and an arrow to indicate the desired shift in therapeutic performance.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/8", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-8", "loopMatches": [ { "to": 12, "from": 5, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "2c2ea794-d311-4166-8444-be0ff8d81ce6", "evidence": "The document uses the golden circle to explain the company's mission and vision", "position": 0, "objective": "Why is this important?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.8, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 8, "from": 5, "beatId": "50cfb41c-c55f-4d71-bad7-662cc5ddaf6c", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem (Identify pain)", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "The document identifies the problem and the need for new approaches", "position": 1, "confidence": 0.9, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "solution", "function": "present_solution", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/9", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-9", "loopMatches": [ { "to": 12, "from": 5, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "2c2ea794-d311-4166-8444-be0ff8d81ce6", "evidence": "The document uses the golden circle to explain the company's mission and vision", "position": 0, "objective": "Why is this important?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.8, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" }, { "to": 12, "from": 9, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f38e4bf0-5d35-4227-a5cd-f584d52537ff", "evidence": "The document highlights the limitations of current treatments and the need for new approaches", "position": 1, "objective": "What are the consequences of not acting?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 12, "from": 9, "beatId": "2c7f8b77-f27b-419f-a0e9-300e30f17da7", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate (Make it worse)", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "The document agitates the problem, highlighting the limitations of current treatments", "position": 2, "confidence": 0.9, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "solution", "function": "present_solution", "notes": "The chart compares Cyno Half-Life vs Human Half-Life, showing YTE mAbs outperforming WT mAbs.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/10", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-10", "loopMatches": [ { "to": 12, "from": 5, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "2c2ea794-d311-4166-8444-be0ff8d81ce6", "evidence": "The document uses the golden circle to explain the company's mission and vision", "position": 0, "objective": "Why is this important?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.8, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" }, { "to": 12, "from": 9, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f38e4bf0-5d35-4227-a5cd-f584d52537ff", "evidence": "The document highlights the limitations of current treatments and the need for new approaches", "position": 1, "objective": "What are the consequences of not acting?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 12, "from": 9, "beatId": "2c7f8b77-f27b-419f-a0e9-300e30f17da7", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate (Make it worse)", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "The document agitates the problem, highlighting the limitations of current treatments", "position": 2, "confidence": 0.9, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a 'before-after' logic to justify the combination strategy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/11", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-11", "loopMatches": [ { "to": 12, "from": 5, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "2c2ea794-d311-4166-8444-be0ff8d81ce6", "evidence": "The document uses the golden circle to explain the company's mission and vision", "position": 0, "objective": "Why is this important?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.8, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" }, { "to": 12, "from": 9, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f38e4bf0-5d35-4227-a5cd-f584d52537ff", "evidence": "The document highlights the limitations of current treatments and the need for new approaches", "position": 1, "objective": "What are the consequences of not acting?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 12, "from": 9, "beatId": "2c7f8b77-f27b-419f-a0e9-300e30f17da7", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate (Make it worse)", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "The document agitates the problem, highlighting the limitations of current treatments", "position": 2, "confidence": 0.9, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "solution", "function": "present_solution", "notes": "Uses a Venn diagram to show target overlap and a bar chart to show clinical efficacy improvement.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/12", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-12", "loopMatches": [ { "to": 12, "from": 5, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "2c2ea794-d311-4166-8444-be0ff8d81ce6", "evidence": "The document uses the golden circle to explain the company's mission and vision", "position": 0, "objective": "Why is this important?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.8, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" }, { "to": 12, "from": 9, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f38e4bf0-5d35-4227-a5cd-f584d52537ff", "evidence": "The document highlights the limitations of current treatments and the need for new approaches", "position": 1, "objective": "What are the consequences of not acting?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 12, "from": 9, "beatId": "2c7f8b77-f27b-419f-a0e9-300e30f17da7", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate (Make it worse)", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "The document agitates the problem, highlighting the limitations of current treatments", "position": 2, "confidence": 0.9, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a Gantt-style visualization to show the progress of various drug candidates (SPY001-SPY230).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/13", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-13", "loopMatches": [ { "to": 30, "from": 13, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "1d2b0809-4269-4aea-a725-b67c9452d570", "evidence": "The document presents the company's solution, including its pipeline and strategy", "position": 2, "objective": "What is the company's solution?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.8, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 30, "from": 13, "beatId": "5fcb9464-3068-4031-9434-ce301bbe9fd3", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents the company's solution, including its pipeline and strategy", "position": 3, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a Gantt-style visualization to show the status of various drug development programs.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/14", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-14", "loopMatches": [ { "to": 30, "from": 13, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "1d2b0809-4269-4aea-a725-b67c9452d570", "evidence": "The document presents the company's solution, including its pipeline and strategy", "position": 2, "objective": "What is the company's solution?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.8, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 30, "from": 13, "beatId": "5fcb9464-3068-4031-9434-ce301bbe9fd3", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents the company's solution, including its pipeline and strategy", "position": 3, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "traction", "function": "show_traction", "notes": "Includes a KOL quote and specific market share metrics for US/EU regions.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/15", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-15", "loopMatches": [ { "to": 30, "from": 13, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "1d2b0809-4269-4aea-a725-b67c9452d570", "evidence": "The document presents the company's solution, including its pipeline and strategy", "position": 2, "objective": "What is the company's solution?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.8, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 30, "from": 13, "beatId": "5fcb9464-3068-4031-9434-ce301bbe9fd3", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents the company's solution, including its pipeline and strategy", "position": 3, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The chart uses a dual-axis approach to imply a safety-efficacy trade-off, positioning vedolizumab as the 'safest' and highly effective.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/16", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-16", "loopMatches": [ { "to": 30, "from": 13, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "1d2b0809-4269-4aea-a725-b67c9452d570", "evidence": "The document presents the company's solution, including its pipeline and strategy", "position": 2, "objective": "What is the company's solution?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.8, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 30, "from": 13, "beatId": "5fcb9464-3068-4031-9434-ce301bbe9fd3", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents the company's solution, including its pipeline and strategy", "position": 3, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The slide uses a checkmark/empty circle matrix to highlight competitive differentiation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/17", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-17", "loopMatches": [ { "to": 30, "from": 13, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "1d2b0809-4269-4aea-a725-b67c9452d570", "evidence": "The document presents the company's solution, including its pipeline and strategy", "position": 2, "objective": "What is the company's solution?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.8, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 30, "from": 13, "beatId": "5fcb9464-3068-4031-9434-ce301bbe9fd3", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents the company's solution, including its pipeline and strategy", "position": 3, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a central antibody diagram to annotate specific technical improvements over 1st generation mAbs.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/18", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-18", "loopMatches": [ { "to": 30, "from": 13, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "1d2b0809-4269-4aea-a725-b67c9452d570", "evidence": "The document presents the company's solution, including its pipeline and strategy", "position": 2, "objective": "What is the company's solution?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.8, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 30, "from": 13, "beatId": "5fcb9464-3068-4031-9434-ce301bbe9fd3", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents the company's solution, including its pipeline and strategy", "position": 3, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "solution", "function": "present_solution", "notes": "Includes structural biology visualization and dose-response curves for two different adhesion targets.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/19", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-19", "loopMatches": [ { "to": 30, "from": 13, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "1d2b0809-4269-4aea-a725-b67c9452d570", "evidence": "The document presents the company's solution, including its pipeline and strategy", "position": 2, "objective": "What is the company's solution?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.8, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 30, "from": 13, "beatId": "5fcb9464-3068-4031-9434-ce301bbe9fd3", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents the company's solution, including its pipeline and strategy", "position": 3, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "product_demo", "function": "present_solution", "notes": "The slide demonstrates bio-equivalence in binding affinity to a specific T-cell population.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/20", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-20", "loopMatches": [ { "to": 30, "from": 13, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "1d2b0809-4269-4aea-a725-b67c9452d570", "evidence": "The document presents the company's solution, including its pipeline and strategy", "position": 2, "objective": "What is the company's solution?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.8, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 30, "from": 13, "beatId": "5fcb9464-3068-4031-9434-ce301bbe9fd3", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents the company's solution, including its pipeline and strategy", "position": 3, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "traction", "function": "show_traction", "notes": "The chart compares SPY001 against two vedolizumab datasets (internal and Takeda).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/21", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-21", "loopMatches": [ { "to": 30, "from": 13, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "1d2b0809-4269-4aea-a725-b67c9452d570", "evidence": "The document presents the company's solution, including its pipeline and strategy", "position": 2, "objective": "What is the company's solution?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.8, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 30, "from": 13, "beatId": "5fcb9464-3068-4031-9434-ce301bbe9fd3", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents the company's solution, including its pipeline and strategy", "position": 3, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "Uses YTE modification as a mechanism for half-life extension.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/22", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-22", "loopMatches": [ { "to": 30, "from": 13, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "1d2b0809-4269-4aea-a725-b67c9452d570", "evidence": "The document presents the company's solution, including its pipeline and strategy", "position": 2, "objective": "What is the company's solution?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.8, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 30, "from": 13, "beatId": "5fcb9464-3068-4031-9434-ce301bbe9fd3", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents the company's solution, including its pipeline and strategy", "position": 3, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "comparison_table", "function": "compare_peers", "notes": "The slide uses a visual timeline/comparison to contrast the competitor's high-frequency, citrate-containing formulation with the company's low-frequency, citrate-free formulation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/23", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-23", "loopMatches": [ { "to": 30, "from": 13, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "1d2b0809-4269-4aea-a725-b67c9452d570", "evidence": "The document presents the company's solution, including its pipeline and strategy", "position": 2, "objective": "What is the company's solution?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.8, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 30, "from": 13, "beatId": "5fcb9464-3068-4031-9434-ce301bbe9fd3", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents the company's solution, including its pipeline and strategy", "position": 3, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "why_now", "function": "argue_timing", "notes": "The chart compares benchmark induction remission rates with vedolizumab exposure quartiles.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/24", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-24", "loopMatches": [ { "to": 30, "from": 13, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "1d2b0809-4269-4aea-a725-b67c9452d570", "evidence": "The document presents the company's solution, including its pipeline and strategy", "position": 2, "objective": "What is the company's solution?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.8, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 30, "from": 13, "beatId": "5fcb9464-3068-4031-9434-ce301bbe9fd3", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents the company's solution, including its pipeline and strategy", "position": 3, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "appendix_data", "function": "analyze_data", "notes": "Data from GEMINI 1 study; highlights that higher drug concentration does not necessarily correlate with higher efficacy in maintenance.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/25", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-25", "loopMatches": [ { "to": 30, "from": 13, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "1d2b0809-4269-4aea-a725-b67c9452d570", "evidence": "The document presents the company's solution, including its pipeline and strategy", "position": 2, "objective": "What is the company's solution?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.8, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 30, "from": 13, "beatId": "5fcb9464-3068-4031-9434-ce301bbe9fd3", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents the company's solution, including its pipeline and strategy", "position": 3, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a standard 2x2 grid for program summary and a simple timeline for catalysts.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/26", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-26", "loopMatches": [ { "to": 30, "from": 13, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "1d2b0809-4269-4aea-a725-b67c9452d570", "evidence": "The document presents the company's solution, including its pipeline and strategy", "position": 2, "objective": "What is the company's solution?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.8, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 30, "from": 13, "beatId": "5fcb9464-3068-4031-9434-ce301bbe9fd3", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents the company's solution, including its pipeline and strategy", "position": 3, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "peer_benchmark", "function": "compare_peers", "notes": "Uses historical peer data (Morphic, Prometheus) to project value inflection points for SPY001.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/27", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-27", "loopMatches": [ { "to": 30, "from": 13, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "1d2b0809-4269-4aea-a725-b67c9452d570", "evidence": "The document presents the company's solution, including its pipeline and strategy", "position": 2, "objective": "What is the company's solution?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.8, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 30, "from": 13, "beatId": "5fcb9464-3068-4031-9434-ce301bbe9fd3", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents the company's solution, including its pipeline and strategy", "position": 3, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "comparison_table", "function": "compare_peers", "notes": "The slide uses a comparison table to establish competitive positioning.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/28", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-28", "loopMatches": [ { "to": 30, "from": 13, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "1d2b0809-4269-4aea-a725-b67c9452d570", "evidence": "The document presents the company's solution, including its pipeline and strategy", "position": 2, "objective": "What is the company's solution?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.8, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 30, "from": 13, "beatId": "5fcb9464-3068-4031-9434-ce301bbe9fd3", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents the company's solution, including its pipeline and strategy", "position": 3, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 29, "slideType": "testimonial", "function": "illustrate_case", "notes": "The slide uses qualitative expert feedback to support quantitative preference share data.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/29", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-29", "loopMatches": [ { "to": 30, "from": 13, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "1d2b0809-4269-4aea-a725-b67c9452d570", "evidence": "The document presents the company's solution, including its pipeline and strategy", "position": 2, "objective": "What is the company's solution?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.8, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 30, "from": 13, "beatId": "5fcb9464-3068-4031-9434-ce301bbe9fd3", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents the company's solution, including its pipeline and strategy", "position": 3, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 30, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a table-like layout to represent a drug development pipeline.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/30", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-30", "loopMatches": [ { "to": 30, "from": 13, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "1d2b0809-4269-4aea-a725-b67c9452d570", "evidence": "The document presents the company's solution, including its pipeline and strategy", "position": 2, "objective": "What is the company's solution?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.8, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 30, "from": 13, "beatId": "5fcb9464-3068-4031-9434-ce301bbe9fd3", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents the company's solution, including its pipeline and strategy", "position": 3, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 31, "slideType": "comparison_table", "function": "compare_peers", "notes": "The chart uses a horizontal bar format to compare clinical remission percentages across different drug targets (TL1A, a4b7, IL-23s, TNFa, S1P1s, JAKs).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/31", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-31", "loopMatches": [], "arcBeatMatches": [ { "to": 44, "from": 31, "beatId": "5c590fe3-bdd5-4bd1-85d4-420b5f2a4608", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "The document provides evidence to support the company's solution", "position": 4, "confidence": 0.9, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 32, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The slide uses a checkmark matrix to highlight the superiority of SPY002.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/32", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-32", "loopMatches": [], "arcBeatMatches": [ { "to": 44, "from": 31, "beatId": "5c590fe3-bdd5-4bd1-85d4-420b5f2a4608", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "The document provides evidence to support the company's solution", "position": 4, "confidence": 0.9, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 33, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a Y-shaped antibody diagram to annotate specific technical improvements.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/33", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-33", "loopMatches": [], "arcBeatMatches": [ { "to": 44, "from": 31, "beatId": "5c590fe3-bdd5-4bd1-85d4-420b5f2a4608", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "The document provides evidence to support the company's solution", "position": 4, "confidence": 0.9, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 34, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "Includes visual representation of antibody binding mechanisms.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/34", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-34", "loopMatches": [], "arcBeatMatches": [ { "to": 44, "from": 31, "beatId": "5c590fe3-bdd5-4bd1-85d4-420b5f2a4608", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "The document provides evidence to support the company's solution", "position": 4, "confidence": 0.9, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 35, "slideType": "solution", "function": "present_solution", "notes": "The slide uses two charts: a dose-response curve (left) and a scatter plot (right) to demonstrate competitive advantage.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/35", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-35", "loopMatches": [], "arcBeatMatches": [ { "to": 44, "from": 31, "beatId": "5c590fe3-bdd5-4bd1-85d4-420b5f2a4608", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "The document provides evidence to support the company's solution", "position": 4, "confidence": 0.9, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 36, "slideType": "solution", "function": "present_solution", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/36", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-36", "loopMatches": [], "arcBeatMatches": [ { "to": 44, "from": 31, "beatId": "5c590fe3-bdd5-4bd1-85d4-420b5f2a4608", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "The document provides evidence to support the company's solution", "position": 4, "confidence": 0.9, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 37, "slideType": "solution", "function": "present_solution", "notes": "The visual uses a mountain-climbing metaphor to represent indication expansion.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/37", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-37", "loopMatches": [], "arcBeatMatches": [ { "to": 44, "from": 31, "beatId": "5c590fe3-bdd5-4bd1-85d4-420b5f2a4608", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "The document provides evidence to support the company's solution", "position": 4, "confidence": 0.9, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 38, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a matrix-like layout to map targets and programs against development stages.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/38", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-38", "loopMatches": [], "arcBeatMatches": [ { "to": 44, "from": 31, "beatId": "5c590fe3-bdd5-4bd1-85d4-420b5f2a4608", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "The document provides evidence to support the company's solution", "position": 4, "confidence": 0.9, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 39, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a biological process diagram to illustrate the mechanism of action for three drug candidates.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/39", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-39", "loopMatches": [], "arcBeatMatches": [ { "to": 44, "from": 31, "beatId": "5c590fe3-bdd5-4bd1-85d4-420b5f2a4608", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "The document provides evidence to support the company's solution", "position": 4, "confidence": 0.9, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 40, "slideType": "comparison_table", "function": "compare_peers", "notes": "The chart uses a waterfall-style logic to show the additive effect of the combination therapy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/40", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-40", "loopMatches": [], "arcBeatMatches": [ { "to": 44, "from": 31, "beatId": "5c590fe3-bdd5-4bd1-85d4-420b5f2a4608", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "The document provides evidence to support the company's solution", "position": 4, "confidence": 0.9, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 41, "slideType": "comparison_table", "function": "compare_peers", "notes": "The slide uses donut charts to represent remission rates and highlights the safety advantages of gut-selective backbones.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/41", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-41", "loopMatches": [], "arcBeatMatches": [ { "to": 44, "from": 31, "beatId": "5c590fe3-bdd5-4bd1-85d4-420b5f2a4608", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "The document provides evidence to support the company's solution", "position": 4, "confidence": 0.9, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 42, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a timeline-based process diagram to illustrate the clinical trial strategy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/42", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-42", "loopMatches": [], "arcBeatMatches": [ { "to": 44, "from": 31, "beatId": "5c590fe3-bdd5-4bd1-85d4-420b5f2a4608", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "The document provides evidence to support the company's solution", "position": 4, "confidence": 0.9, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-3cec-7700-94db-076a5ce30d84", "docSlug": "8c2d629a90974743be7d15f16a23e50f", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 43, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a Y-shaped antibody illustration to represent the combination therapy approach.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-3cec-7700-94db-076a5ce30d84/43", "deckHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84", "deckAnchorHref": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-43", "loopMatches": [], "arcBeatMatches": [ { "to": 44, "from": 31, "beatId": "5c590fe3-bdd5-4bd1-85d4-420b5f2a4608", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "The document provides evidence to support the company's solution", "position": 4, "confidence": 0.9, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }